NASDAQ:HSIC Henry Schein (HSIC) Stock Price, News & Analysis $84.96 -1.26 (-1.46%) Closing price 04:00 PM EasternExtended Trading$84.94 -0.02 (-0.02%) As of 05:19 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Henry Schein Stock (NASDAQ:HSIC) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Henry Schein alerts:Sign Up Key Stats Today's Range$83.87▼$86.2250-Day Range$82.50▼$89.8152-Week Range$68.70▼$92.18Volume1.71 million shsAverage Volume1.36 million shsMarket Capitalization$9.39 billionP/E Ratio23.28Dividend YieldN/APrice Target$93.57Consensus RatingModerate Buy Company Overview Henry Schein, Inc. is a global distributor of health care products and services, serving dental and medical practitioners, veterinary professionals, and other health care organizations. The company traces its roots to a pharmacy founded by Henry and Esther Schein in Queens, New York, in 1932. Its offerings include medical and dental supplies, equipment, pharmaceuticals, vaccines, and diagnostic products. Henry Schein also provides practice-management software, technology solutions, and business services designed to help health care professionals manage their operations. The company serves customers across North America and international markets, including Europe, Asia-Pacific, and other regions. Its customer base includes independent practices as well as clinics, laboratories, and institutional health care providers.AI Generated. May Contain Errors. Read More Henry Schein Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks47th Percentile Overall ScoreHSIC MarketRank™: 2.327014846235 of 5 starsHenry Schein scored higher than 47% of companies evaluated by MarketBeat, and ranked 575th out of 877 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.9 / 5Analyst RatingModerate Buy Consensus RatingHenry Schein has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on no strong buy ratings, 8 buy ratings, 5 hold ratings, and 1 sell rating.Upside PotentialHenry Schein has a consensus price target of $93.57, representing about 10.2% upside from its current price of $84.90.Amount of Analyst CoverageHenry Schein has only been the subject of 4 research reports in the past 90 days.Read more about Henry Schein's stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth7.57% Earnings GrowthEarnings for Henry Schein are expected to grow by 7.57% in the coming year, from $5.55 to $5.97 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Henry Schein is 23.19, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 26.17.Price to Earnings Ratio vs. SectorThe P/E ratio of Henry Schein is 23.19, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 34.34.Price to Earnings Growth RatioHenry Schein has a PEG Ratio of 1.51. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioHenry Schein has a P/B Ratio of 2.56. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted8.54% of the float of Henry Schein has been sold short.Short Interest Ratio / Days to CoverHenry Schein has a short interest ratio ("days to cover") of 8.3.Change versus previous monthShort interest in Henry Schein has recently increased by 3.95%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldHenry Schein does not currently pay a dividend.Dividend GrowthHenry Schein does not have a long track record of dividend growth. News and Social Media2.0 / 5News Sentiment0.13 News SentimentHenry Schein has a news sentiment score of 0.13. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.59 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 8 news articles for Henry Schein this week, compared to 6 articles on an average week.Search InterestOnly 1 people have searched for HSIC on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Henry Schein to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership0.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Henry Schein insiders have not sold or bought any company stock.Percentage Held by Insiders0.89% of the stock of Henry Schein is held by insiders.Percentage Held by Institutions96.62% of the stock of Henry Schein is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Henry Schein's insider trading history. Receive HSIC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Henry Schein and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. HSIC Stock News HeadlinesHenry Schein Lowers 2026 Non-GAAP EPS OutlookNovember 16 at 8:48 AM | marketscreener.comM(HSIC) Henry Schein Expects 2026 Adjusted EPS Range $5.42 to $5.48, vs. FactSet Est of $5.52November 16 at 8:48 AM | marketscreener.comMA $247 tool for $7Bill Poulos is offering his $247 Instant Scanner for $7 in the Black Friday sale. It's one payment for a full year, with no re-bills and nothing to install. The catch? He isn't trying to profit on the scanner itself. Poulos is betting that once you see it deliver the night's list, you'll want more of his work for years.November 16 at 1:00 AM | Profits Run (Ad)Henry Schein Updates Presentation of Non-GAAP Financial MeasuresNovember 16 at 8:48 AM | finance.yahoo.comHenry Schein lowers 2026 adjusted EPS guidance following change to non-GAAP reportingNovember 16 at 8:48 AM | msn.comHenry Schein Updates Non-GAAP Measures and Recasts Historical ResultsNovember 16 at 7:11 AM | tipranks.comHenry Schein (NASDAQ:HSIC) Stock Price Expected to Rise, UBS Group Analyst SaysNovember 6, 2026 | americanbankingnews.comBank of America Securities Keeps Their Buy Rating on Henry Schein (HSIC)November 5, 2026 | theglobeandmail.comSee More Headlines HSIC Stock Analysis - Frequently Asked Questions How have HSIC shares performed this year? Henry Schein's stock was trading at $75.58 at the start of the year. Since then, HSIC stock has increased by 12.3% and is now trading at $84.9030. How were Henry Schein's earnings last quarter? Henry Schein, Inc. (NASDAQ:HSIC) posted its earnings results on Tuesday, November, 3rd. The company reported $1.56 earnings per share for the quarter, topping analysts' consensus estimates of $1.36 by $0.20. The company's revenue was up 4.0% on a year-over-year basis. Read the conference call transcript. When did Henry Schein's stock split? Shares of Henry Schein split before market open on Friday, September 15th 2017.The 2-1 split was announced on Wednesday, August 16th 2017. The newly issued shares were payable to shareholders after the closing bell on Thursday, September 14th 2017. An investor that had 100 shares of stock prior to the split would have 200 shares after the split. Does Henry Schein have any subsidiaries? Henry Schein subsidiaries include these companies: Prism Medical Products LLC, Elite Computer Italia, Southern Anesthesia & Surgical, Marrodent, Dental Cremer, RxWorks, Dental Trey, and others. Who are Henry Schein's major shareholders? Top institutional investors of Henry Schein include Gamco Investors INC. ET AL (0.33%), Gabelli Funds LLC (0.26%), Russell Investments Group Ltd. (0.16%) and Banyan Capital Management Inc. (0.09%). Insiders that own company stock include Stanley M Bergman, James P Breslawski, Michael S Ettinger, Thomas C Popeck, Mark E Mlotek, Lorelei Mcglynn, Bradford C Connett, Philip A Laskawy and Kurt P Kuehn. View institutional ownership trends. How do I buy shares of Henry Schein? Shares of HSIC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Henry Schein own? Based on aggregate information from My MarketBeat watchlists, some other companies that Henry Schein investors own include Alibaba Group (BABA), Walt Disney (DIS), Bristol Myers Squibb (BMY), CVS Health (CVS), Bank of America (BAC), Advanced Micro Devices (AMD) and Amgen (AMGN). Company Calendar Last Earnings11/03/2026Today11/16/2026Jefferies Global Healthcare Conference11/17/202638th Annual Healthcare Conference12/01/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (5m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 HSIC's financial health is in the Green zone, according to TradeSmith. HSIC has been in this zone for over 5 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryHealthcare Distributors Current SymbolNASDAQ:HSIC CIK1000228 Webwww.henryschein.com Phone(631) 843-5500Fax631-843-5541Employees25,000Year Founded1932Price Target and Rating Average Price Target for Henry Schein$93.57 High Price Target$112.00 Low Price Target$64.00 Potential Upside/Downside+10.1%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage14 Analysts Profitability EPS (Trailing Twelve Months)$3.65 Trailing P/E Ratio23.28 Forward P/E Ratio14.23 P/E Growth1.51Net Income$398 million Net Margins3.07% Pretax Margin4.22% Return on Equity16.39% Return on Assets5.58% Debt Debt-to-Equity Ratio0.62 Current Ratio1.33 Quick Ratio0.76 Sales & Book Value Annual Sales$13.18 billion Price / Sales0.71 Cash Flow$7.67 per share Price / Cash Flow11.08 Book Value$33.12 per share Price / Book2.57Miscellaneous Outstanding Shares110,540,000Free Float109,555,000Market Cap$9.39 billion OptionableOptionable Beta0.87 Social Links The 7 Best High-Yield Dividend Stocks for 2027Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.Get This Free Report This page (NASDAQ:HSIC) was last updated on 11/16/2026 by MarketBeat.com Staff. From Our PartnersA $247 tool for $7Bill Poulos is offering his $247 Instant Scanner for $7 in the Black Friday sale. It's one payment for a full ...Profits Run | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredFDA clears next-gen therapy with 10 to 40 times greater potencyTime-lapse footage from a recent clinical study shows Natural Killer cells attacking and eliminating cancer ce...Market Tactic | SponsoredPentagon magnet restrictions take effect January 1, 2027A NASDAQ-listed company has signed a term sheet outlining a potential 75-year agreement with the U.S. Army. It...OilPrice | SponsoredYour Copy is on Hold (Claim it now)James Altucher, who called NVIDIA in 2008 and SpaceX years before a single share traded, has a new report on E...Paradigm Press | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Henry Schein, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Henry Schein With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.